| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637 [R. R. W., D. E. H., M. A. B., H. J. M., H. L.]; Section of Nephrology, Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02114 [V. P. S.]; and Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115 [D. W. K.]
Transcriptional regulation of the promoter/enhancer region of the Egr-1 gene is activated by ionizing radiation. We linked DNA sequences from the promotor region of Egr-1 to a complementary DNA sequence which encodes human tumor necrosis factor (TNF)
, a radiosensitizing cytokine. The Egr-TNF construct was transfected into a human cell line of hematopoietic origin, HL525, which was used in an experimental animal system. HL525 (clone 2) cells containing the Egr-TNF construct which exhibits radiation induction of TNF-
were injected into human xenografts of the radioresistant human squamous cell carcinoma cell line SQ-20B. Animals treated with radiation and clone 2 demonstrated an increase in tumor cures compared with animals treated with radiation alone or unirradiated animals given injections of clone 2 alone. No increase in local or systemic toxicity was observed in the combined treatment group. The combination of gene therapy and radiation therapy enhances tumor cures without increasing normal tissue toxicity and is a new paradigm for cancer treatment.
1 This research was supported by a gift from the Daniel F. and Ada L. Rice Foundation; Grants CA 58505, CA 41068, and CA 42596 from the National Cancer Institute; the Center for Radiation Therapy; and a gift from the Passis family.
Received 6/ 2/94. Accepted 7/ 1/94.
This article has been cited by other articles:
![]() |
K. Twigger, L. Vidal, C. L. White, J. S. De Bono, S. Bhide, M. Coffey, B. Thompson, R. G. Vile, L. Heinemann, H. S. Pandha, et al. Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy Clin. Cancer Res., February 1, 2008; 14(3): 912 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zeira, A. Manevitch, Z. Manevitch, E. Kedar, M. Gropp, N. Daudi, R. Barsuk, M. Harati, H. Yotvat, P. J. Troilo, et al. Femtosecond laser: a new intradermal DNA delivery method for efficient, long-term gene expression and genetic immunization FASEB J, November 1, 2007; 21(13): 3522 - 3533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jung, Y. Zhang, A. Dimtchev, M. R. Subramanian, K. Suthanthiran, and A. Dritschilo Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds Mol. Cancer Ther., June 1, 2004; 3(6): 655 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. K. Hu, A. Krol, Y.-P. Li, C.-Y. Li, and F. Yuan Systemic dissemination of viral vectors during intratumoral injection Mol. Cancer Ther., November 1, 2003; 2(11): 1233 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Vorburger and K. K. Hunt Adenoviral Gene Therapy Oncologist, February 1, 2002; 7(1): 46 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Anscher, L. B. Marks, T. D. Shafman, R. Clough, H. Huang, A. Tisch, M. Munley, J. E. Herndon II, J. Garst, J. Crawford, et al. Using Plasma Transforming Growth Factor Beta-1 During Radiotherapy to Select Patients for Dose Escalation J. Clin. Oncol., September 1, 2001; 19(17): 3758 - 3765. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Borrelli, D. M. Schoenherr, A. Wong, L. J. Bernock, and P. M. Corry Heat-activated Transgene Expression from Adenovirus Vectors Infected into Human Prostate Cancer Cells Cancer Res., February 1, 2001; 61(3): 1113 - 1121. [Abstract] [Full Text] |
||||
![]() |
Q. Huang, J. K. Hu, F. Lohr, L. Zhang, R. Braun, J. Lanzen, J. B. Little, M. W. Dewhirst, and C.-Y. Li Heat-induced Gene Expression as a Novel Targeted Cancer Gene Therapy Strategy Cancer Res., July 1, 2000; 60(13): 3435 - 3439. [Abstract] [Full Text] |
||||
![]() |
W. R. Joseph, Z. Cao, K. G. Mountjoy, E. S. Marshall, B. C. Baguley, and L.-M. Ching Stimulation of Tumors to Synthesize Tumor Necrosis Factor-{{alpha}} in Situ Using 5,6-Dimethylxanthenone-4-acetic Acid: A Novel Approach to Cancer Therapy Cancer Res., February 1, 1999; 59(3): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Coleman Modulating the Radiation Response Oncologist, August 1, 1996; 1(4): 227 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Coleman Modulating the radiation response Stem Cells, January 1, 1996; 14(1): 10 - 15. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |